Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

Cigna has brought merger talks with Humana back from the dead, according to a new report in Bloomberg.

(Reuters) - U.S. health insurer Cigna Group has revived efforts to merge with smaller rival Humana after abandoning the ...

CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the health care giant struggling on ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

The shift in management is not surprising as the company looks to level set its operations and strategically position itself ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health’s (NYSE:CVS) turnaround could be long and arduous, if it resembles that of drugstore rival Walgreens Boots ...

Taking over for Karen Lynch is pharmacy services veteran David Joyner, who rejoined the company nearly two years ago.

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...